How to diagnose tertiary syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Tertiary Syphilis

The diagnosis of tertiary syphilis requires a combination of clinical evaluation for characteristic manifestations (cardiovascular, neurological, or gummatous lesions), positive serological tests, and specialized testing such as CSF examination when neurosyphilis is suspected. 1

Clinical Manifestations of Tertiary Syphilis

Tertiary syphilis typically presents with one or more of these major manifestations:

  • Gummatous syphilis: Granulomatous lesions that can affect any organ system
  • Cardiovascular syphilis: Aortitis, aortic aneurysm, aortic regurgitation, coronary artery involvement 2
  • Neurosyphilis: Can occur at any stage but in tertiary syphilis presents as tabes dorsalis, general paresis, or meningovascular disease 1

Diagnostic Algorithm

Step 1: Serological Testing

  • Initial screening: Perform nontreponemal test (VDRL or RPR) 1
  • Confirmatory testing: All reactive nontreponemal tests must be confirmed with a treponemal-specific test (FTA-ABS, TP-PA) 1, 3
  • Interpretation:
    • Positive results on both tests strongly suggest current or past infection
    • In tertiary syphilis, nontreponemal titers may be low or even nonreactive in 25-30% of cases 1
    • Treponemal tests typically remain positive for life regardless of treatment 1

Step 2: Clinical Evaluation for Organ Involvement

  • Cardiovascular assessment: Evaluate for aortic regurgitation, aneurysm, or coronary artery disease 2
  • Neurological examination: Look for signs of meningitis, stroke, cranial nerve abnormalities, sensory ataxia, or cognitive decline 1
  • Skin and mucosal examination: Check for gummatous lesions (nodular, noduloulcerative, or infiltrative lesions) 1

Step 3: CSF Examination (Critical for Neurosyphilis)

  • Indications for CSF examination:

    • All patients with neurological or ocular symptoms/signs
    • Active tertiary syphilis
    • Treatment failure
    • HIV-infected persons with late latent syphilis 1
  • CSF findings suggestive of neurosyphilis:

    • Reactive CSF-VDRL (specific but not sensitive)
    • CSF WBC >10 cells/μL (typically mononuclear pleocytosis)
    • Elevated protein concentration
    • Note: A nonreactive CSF treponemal test (e.g., CSF FTA-ABS) can exclude neurosyphilis 1

Special Considerations

HIV Co-infection

  • HIV infection may alter serological responses but doesn't significantly change the performance of standard tests 1
  • More frequent false-positive nontreponemal tests may occur in HIV-infected persons 1
  • CSF examination is recommended for all HIV-infected persons with syphilis of unknown duration or late latent syphilis 1
  • Some specialists recommend CSF examination for all HIV-infected persons with syphilis if serum RPR is ≥1:32 or CD4+ count is <350 cells/μL 1

Diagnostic Pitfalls to Avoid

  • Relying on a single serologic test: Both nontreponemal and treponemal tests are required 1, 3
  • Missing neurosyphilis: CSF examination is essential when neurological symptoms are present 1
  • Misinterpreting persistent low-titer seropositivity: Some patients remain "serofast" after treatment 4
  • Switching between different nontreponemal tests: Use the same test consistently for follow-up 4

Additional Testing When Diagnosis is Uncertain

  • Biopsy of lesions with silver staining for spirochetes
  • Direct fluorescent antibody testing of lesion material
  • PCR-based methods (though not currently recommended for neurosyphilis) 1

Follow-up After Diagnosis

  • Monitor treatment response with quantitative nontreponemal tests at 3,6,12,18, and 24 months 4
  • For neurosyphilis, repeat CSF examination at 3 and 6 months after therapy completion, then every 6 months until CSF normalizes 4

By systematically following this diagnostic approach, clinicians can accurately identify tertiary syphilis and initiate appropriate treatment to prevent further morbidity and mortality from this advanced stage of infection.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cardiovascular Syphilis.

Cardiology in review, 2025

Research

CDC Laboratory Recommendations for Syphilis Testing, United States, 2024.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2024

Guideline

Syphilis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.